Corrigendum: Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
Main Authors: | Daniel Ebrahimi-Fakhari, Ulrich Dillmann, Marina Flotats-Bastardas, Martin Poryo, Hashim Abdul-Khaliq, Mohammed Ghiath Shamdeen, Bernhard Mischo, Michael Zemlin, Sascha Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2019.00284/full |
Similar Items
-
Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
by: Daniel Ebrahimi-Fakhari, et al.
Published: (2018-10-01) -
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
by: S. Ryder, et al.
Published: (2017-04-01) -
Anthropometric indicator assessment pubertal and adolescents with Duchenne Muscular Dystrophy
by: Rodríguez-Hernández Adán Israel, et al.
Published: (2019-02-01) -
Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study
by: Abdelrahim Abdrabou Sadek, et al.
Published: (2017-11-01) -
Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
by: Rasic Milic V., et al.
Published: (2014-12-01)